Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal

Guangbo Zhang1, Jianquan Hou, Jinfang Shi

  • 1Clinical Immunology Laboratory, Suzhou University no. 1 Affiliated Hospital, Suzhou, China.

Immunology
|January 16, 2008
PubMed

Insights

Researchers discovered a soluble form of B7-H3 (sB7-H3) released by immune cells and carcinoma cells. This soluble B7-H3 is functionally active and present at high levels in human serum, suggesting a role in regulating immune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Biology

Background:

  • Membrane CD276 (mB7-H3) is expressed on immune cells and carcinoma cells, but its in vivo function is unclear.
  • The existence and function of a soluble form of B7-H3 (sB7-H3) have not been previously investigated.

Purpose of the Study:

  • To investigate the presence and release of soluble B7-H3 (sB7-H3).
  • To characterize the functional activity of sB7-H3 in vitro and in vivo.
  • To explore the mechanism of sB7-H3 release.

Main Methods:

  • Developed a sensitive dual monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA) to detect sB7-H3.
  • Utilized Western blotting to determine the molecular size of sB7-H3.
  • Investigated the effect of matrix metalloproteinase inhibitors (MMPI) on sB7-H3 release.
  • Analyzed serum samples from over 200 individuals to quantify circulating sB7-H3 levels.
  • Assessed the binding of sB7-H3 to the B7-H3 receptor (B7-H3R) on activated T cells.

Main Results:

  • Demonstrated the release of sB7-H3 by monocytes, dendritic cells (DCs), activated T cells, and mB7-H3+ carcinoma cells.
  • Showed that sB7-H3 release is mediated by matrix metalloproteinases (MMPs) and can be blocked by MMPI.
  • Confirmed high levels of circulating sB7-H3 in all analyzed serum samples.
  • Determined the molecular size of sB7-H3 to be approximately 16 kDa via Western blotting.
  • Confirmed that sB7-H3 is functionally active by demonstrating its binding to B7-H3R on activated T cells.

Conclusions:

  • Soluble B7-H3 (sB7-H3) is actively released from cells, likely via MMP-mediated cleavage.
  • Circulating sB7-H3 is abundant and functionally active, suggesting a significant role in regulating B7-H3R/B7-H3 interactions in vivo.
  • The cleavage of membrane-bound B7-H3 to a soluble form may modulate both proximal and distal cellular responses, impacting immune regulation and potentially cancer progression.